{"id":1692,"date":"2017-09-10T14:45:00","date_gmt":"2017-09-10T04:45:00","guid":{"rendered":"https:\/\/webdev.sydney.edu.au\/kolling\/?post_type=news&p=1692"},"modified":"2026-03-12T14:16:48","modified_gmt":"2026-03-12T03:16:48","slug":"new-medication-may-offer-long-acting-relief-for-those-with-knee-osteoarthritis","status":"publish","type":"news","link":"https:\/\/kollinginstitute.org.au\/news_demo\/news\/new-medication-may-offer-long-acting-relief-for-those-with-knee-osteoarthritis\/","title":{"rendered":"New medication may offer long-acting relief for those with knee osteoarthritis"},"content":{"rendered":"\n

A study has been launched to investigate the benefits of a new injectable medication for those with knee osteoarthritis.<\/p>\n\n\n\n

The condition can have a profound impact on a person\u2019s life, leading to physical limitations, ongoing pain and joint instability.<\/p>\n\n\n\n

There are broader implications too which can make it difficult for those with the condition to engage in social, community and occupational activities.<\/p>\n\n\n\n

Significant resources and expertise are being directed towards the disease, and a number of clinical trials and research studies are underway to develop new interventions and tests that may alleviate the symptoms of the condition.<\/p>\n\n\n\n

One of these promising trials is being led by Professor David Hunter and his team from the Kolling Institute and Royal North Shore Hospital.<\/p>\n\n\n\n

The Excellence Study will evaluate a new injectable medication that has been formulated to provide both short-term and long-acting relief from pain, inflammation and mobility impairments.<\/p>\n\n\n\n

Many current medications for knee osteoarthritis offer only short-term relief, while this new medication may offer relief for up to six months. <\/p>\n\n\n\n

Volunteers are being recruited for the study and further community support is needed.<\/p>\n\n\n\n

Details about the eligibility criteria can be found in the registration survey form.<\/p>\n\n\n\n

Interested volunteers can click on the link provided in the form to register their interest for the study.<\/p>\n\n\n\n

To find out more: https:\/\/redcap.sydney.edu.au\/surveys\/?s=4T7XWDW33T<\/a><\/p>\n\n\n\n

Contact: Tatyana Fedorova 9463 1774<\/p>\n","protected":false},"author":1,"featured_media":1693,"menu_order":0,"template":"","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[12,16],"tags":[42],"research-group-tax":[],"primary-research-area":[],"class_list":["post-1692","news","type-news","status-publish","has-post-thumbnail","hentry","category-musculoskeletal-research","category-new-treatment","tag-musculoskeletal"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/08\/root_Blog_OA-image.jpg",674,450,false],"thumbnail":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/08\/root_Blog_OA-image-150x150.jpg",150,150,true],"medium":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/08\/root_Blog_OA-image-300x200.jpg",300,200,true],"medium_large":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/08\/root_Blog_OA-image.jpg",674,450,false],"large":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/08\/root_Blog_OA-image.jpg",674,450,false],"1536x1536":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/08\/root_Blog_OA-image.jpg",674,450,false],"2048x2048":["https:\/\/kollinginstitute.org.au\/news_demo\/wp-content\/uploads\/2025\/08\/root_Blog_OA-image.jpg",674,450,false]},"uagb_author_info":{"display_name":"ict-wordpress-support@sydney.edu.au","author_link":"https:\/\/kollinginstitute.org.au\/news_demo\/author\/ict-wordpress-supportsydney-edu-au\/"},"uagb_comment_info":0,"uagb_excerpt":"A study has been launched to investigate the benefits of a new injectable medication for those with knee osteoarthritis. The condition can have a profound impact on a person\u2019s life, leading to physical limitations, ongoing pain and joint instability. There are broader implications too which can make it difficult for those with the condition to…","_links":{"self":[{"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/news\/1692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":1,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/news\/1692\/revisions"}],"predecessor-version":[{"id":5270,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/news\/1692\/revisions\/5270"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/media\/1693"}],"wp:attachment":[{"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/media?parent=1692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/categories?post=1692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/tags?post=1692"},{"taxonomy":"research-group-tax","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/research-group-tax?post=1692"},{"taxonomy":"primary-research-area","embeddable":true,"href":"https:\/\/kollinginstitute.org.au\/news_demo\/wp-json\/wp\/v2\/primary-research-area?post=1692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}